Authors:
Rahme, E
Joseph, L
Kong, SX
Watson, DJ
Pellissier, JM
LeLorier, J
Citation: E. Rahme et al., Gastrointestinal-related healthcare resource usage associated with a fixedcombination of diclofenac and misoprostol versus other NSAIDs, PHARMACOECO, 19(5), 2001, pp. 577-588
Authors:
Marshall, JK
Pellissier, JM
Attard, CL
Kong, SX
Marentette, MA
Citation: Jk. Marshall et al., Incremental cost-effectiveness analysis comparing rofecoxib with nonselective NSAIDs in osteoarthritis - Ontario ministry of health perspective, PHARMACOECO, 19(10), 2001, pp. 1039-1049
Authors:
Pellissier, JM
Straus, WL
Watson, DJ
Kong, SX
Harper, SE
Citation: Jm. Pellissier et al., Economic evaluation of rofecoxib versus nonselective nonsteroidal anti-inflammatory drugs for the treatment of osteoarthritis, CLIN THER, 23(7), 2001, pp. 1061-1079
Authors:
Pellissier, JM
Coplan, PM
Jackson, LA
May, JE
Citation: Jm. Pellissier et al., The effect of additional shots on the vaccine administration process: Results of a time-motion study in 2 settings, AM J M CARE, 6(9), 2000, pp. 1038-1044
Authors:
Albertsen, PC
Pellissier, JM
Lowe, FC
Girman, CJ
Roehrborn, CG
Citation: Pc. Albertsen et al., Economic analysis of finasteride: A model-based approach using data from the Proscar (R) long-term efficacy and safety study, CLIN THER, 21(6), 1999, pp. 1006-1024